The anti-inflammatory and cytoprotective effects of HO-1 have been previously observed in different models of renal disease, often hindered by the lack of an appropriate HO-1 inducer (Bolisetty et al., 2017; Zhang et al., 2018). The gene discussed is HMOX1; the disease is kidney disorder.